摘要:
The present invention relates to genetically modified cyclic nucleotide-gated ion channels whose subunits have been altered so as to have higher sensitivity to cAMP and/or higher selectivity for cAMP compared to cGMP in comparison with the wild type according to SEQ ID NO 1 and 2.
摘要翻译:本发明涉及基因修饰的环核苷酸门控离子通道,其与根据SEQ ID NO:1和2的野生型相比,其亚基已被改变以具有比cAMP高的cAMP敏感性和/或cCMP的较高选择性 。
摘要:
A genetically modified cyclic-nucleotide controlled ion channels where the subunits thereof are altered in such a manner that they have a higher sensitivity for cAMP in relation to cGMP in comparison with the Wildtype according to Seq ID No. 1 and 2.
摘要翻译:基因修饰的环核苷酸控制的离子通道,其亚基以相对于cGMP相对于cGMP具有更高灵敏度的方式改变,与根据Seq ID No.1和2的野生型相比。
摘要:
The present invention relates to genetically modified cyclic nucleotide-gated ion channels whose subunits have been altered so as to have higher sensitivity to cAMP and/or higher selectivity for cAMP compared to cGMP in comparison with the wild type according to SEQ ID NO 1 and 2.
摘要翻译:本发明涉及基因修饰的环核苷酸门控离子通道,其与根据SEQ ID NO:1和2的野生型相比,其亚基已被改变以具有比cAMP高的cAMP敏感性和/或cCMP的较高选择性 。
摘要:
The present invention relates to a nucleic acid, preferably a DNA, comprising at least a part of the sequence of an Ih ion channel. Said sequence may e.g. be derived from a human DNA, a rat DNA, a bovine DNA, a Drosophila melanogaster DNA or a sea urchin DNA. Furthermore, the present invention relates to an mRNA molecule which contains the corresponding sequences. The invention further relates to a polypeptide or protein encoded by the nucleic acid.Furthermore, the invention relates to the use of the inventive nucleic acid and proteins for a screening and/or diagnosing method and to the kits required therefor.Lastly, the invention relates to the use of one or more nucleic acids and proteins for the treatment and/or prophylaxis of cardiovascular disorders and disturbances of consciousness.
摘要翻译:本发明涉及一种核酸,优选DNA,其包含至少一部分I H H离子通道的序列。 所述序列可以例如。 衍生自人类DNA,大鼠DNA,牛DNA,果蝇黑腹果蝇DNA或海胆DNA。 此外,本发明涉及含有相应序列的mRNA分子。 本发明还涉及由该核酸编码的多肽或蛋白质。 此外,本发明涉及本发明的核酸和蛋白质用于筛选和/或诊断方法及其所需的试剂盒的用途。 最后,本发明涉及一种或多种核酸和蛋白质用于治疗和/或预防心血管疾病和意识障碍的用途。
摘要:
The present invention relates to a type PepT1 protein assay and in particular a process for identifying a substrate and/or a modulator of the PepT1 protein.
摘要:
The present invention relates to an isolated or purified human nucleic acid, preferably a DNA, comprising a nucleotide sequence encoding an Ih ion channel. The invention further relates to a vector comprising the isolated or purified nucleic acid, a host cell comprising the vector, and a composition comprising the isolated or purified nucleic acid and a carrier therefore. The invention also provides a polypeptide or protein encoded by the nucleic acid, and a method of treating a mammal for a cardiovascular disorder.
摘要:
The present invention relates to an isolated or purified human nucleic acid, preferably a DNA, comprising a nucleotide sequence encoding an Ih ion channel. The invention further relates to a vector comprising the isolated or purified nucleic acid, a host cell comprising the vector, and a composition comprising the isolated or purified nucleic acid and a carrier therefore. The invention also provides a polypeptide or protein encoded by the nucleic acid, and a method of treating a mammal for a cardiovascular disorder.
摘要翻译:本发明涉及分离或纯化的人核酸,优选DNA,其包含编码I H h离子通道的核苷酸序列。 本发明还涉及包含分离或纯化的核酸的载体,包含载体的宿主细胞,以及包含分离或纯化的核酸和载体的组合物。 本发明还提供了由核酸编码的多肽或蛋白质,以及治疗哺乳动物心血管疾病的方法。